NEW YORK, NY / ACCESSWIRE / July 7, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Recro Pharma, Inc. (“Recro” or the “Company”) (NASDAQ: REPH) and certain of its officers. The class action, filed in United …
Go to Source